Biology subjects

Meier, M. J.

Publications and source records attributed to Meier, M. J..

3 recordsLinked to original sources

bioRxiv2026

A robust mutation spectrum analysis framework for high-depth error-corrected sequencing data

Comparing mutational spectra across experimental groups requires inference at the level of the biological replicate. Error-corrected sequencing (ECS) generates hundreds to thousands of mutations per replicate, yet classical pooled G2 tests treat individual mutations as independent observations and ignore replicate-level variability, inflating statistical significance (pseudo-replication). We present a replicate-aware Ridge-Penalized Dirichlet-Multinomial (RP-DMM) framework that models biological replicates directly and accounts for overdispersion. An L2 (ridge) penalty, with strength chosen by leave-one-out cross-validation, stabilizes spectrum estimates by shrinking weakly supported mutation categories toward a common baseline, and inference uses a parametric bootstrap. We also provide a complementary non-parametric rank-permutation test for sparse datasets. In simulations, the pooled G2 test became increasingly anti-conservative as mutation depth increased, with false-positive rates approaching 100% under the null hypothesis. RP-DMM maintained Type I error near the nominal 5% level and had substantially greater power than the rank-permutation test. Regularization was most consequential for high-dimensional spectra. False positive rates approached the nominal 5% level once the lower-mutation group contained approximately 300-500 mutations, depending on the number of biological replicates. A practical target of approximately 400 mutations in the lower-mutation group provided robust Type I error control across all scenarios examined; below this, the rank-permutation test performed robustly and is preferred. In Duplex Sequencing data from benzo[a]pyrene-exposed mice, RP-DMM distinguished exposure-associated mutational signatures from comparisons with higher mutation counts but null effect size, whereas the pooled G2 test declared all comparisons significant. The cross-validated penalty decreased as mutation depth increased, indicating that regularization strength should be tuned to the data. The framework is implemented in the MutSeqR R package.

bioinformatics↗

bioRxiv2024

Dose-related Mutagenic and Clastogenic Effects of Benzofluoranthene in Mouse Somatic Tissues Detected by Duplex Sequencing and the Micronucleus Assay

Polycyclic aromatic hydrocarbons (PAHs) are common environmental pollutants that originate from the incomplete combustion of organic materials. We investigated the clastogenicity and mutagenicity of benzo[b]fluoranthene (BbF), one of 16 priority PAHs, in MutaMouse males after a 28-day oral exposure. BbF causes robust dose-dependent increases in micronucleus frequency in peripheral blood, indicative of chromosome damage. Duplex Sequencing (DS), an error-corrected sequencing technology, reveals that BbF induces dose-dependent increases in mutation frequencies in bone marrow (BM) and liver. Mutagenicity is increased in intergenic relative to genic regions, suggesting a role for transcription-coupled repair of BbF-induced DNA damage. At higher doses, the maximum mutagenic response to BbF is higher in liver, which has a lower mitotic index but higher metabolic capacity than BM; however, mutagenic potency is comparable between the two tissues. BbF induces primarily C:G>A:T mutations, followed by C:G>T:A and C:G>G:C, indicating that BbF metabolites mainly target guanines and cytosines. The mutation spectrum of BbF correlates with cancer mutational signatures associated with tobacco exposure, supporting its contribution to the carcinogenicity of combustion-derived PAHs in humans. Overall, BbFs mutagenic effects are similar to benzo[a]pyrene, a well-studied mutagenic PAH. Our work showcases the utility of DS for effective mutagenicity assessment of environmental pollutants. SynopsisWe used Duplex Sequencing to study the mutagenicity of benzo[b]fluoranthene across the mouse genome. Dose-dependent changes in mutation frequency and spectrum quantify its role in PAH-induced carcinogenicity.

pharmacology and toxicology↗

bioRxiv2019

SEQUENCING CHEMICALLY INDUCED MUTATIONS IN THE MUTAMOUSE LACZ REPORTER GENE IDENTIFIES HUMAN CANCER MUTATIONAL SIGNATURES

Transgenic rodent (TGR) models use bacterial reporter genes to quantify in vivo mutagenesis. Pairing TGR assays with next-generation sequencing (NGS) enables comprehensive mutation spectrum analysis to inform mutational mechanisms. We used this approach to identify 2,751 independent lacZ mutations in the bone marrow of MutaMouse animals exposed to four chemical mutagens: benzo[a]pyrene, N-ethyl-N-nitrosourea, procarbazine, and triethylenemelamine. We also collected published data for 706 lacZ mutations from eight additional environmental mutagens. We demonstrate that lacZ gene sequencing generates chemical-specific mutation signatures observed in human cancers with established environmental causes. For example, the mutation signature of benzo[a]pyrene, a potent carcinogen in tobacco smoke, matched the signature associated with tobacco-induced lung cancers. Our results show that the analysis of chemically induced mutations in the lacZ gene shortly after exposure provides an effective approach to characterize human-relevant mechanisms of carcinogenesis and identify novel environmental causes of mutation signatures observed in human cancers.

genetics↗